110 related articles for article (PubMed ID: 12359140)
1. Immune response to enzyme replacement therapy: single epitope control of antigen distribution from circulation.
Glaros EN; Turner CT; Parkinson EJ; Hopwood JJ; Brooks DA
Mol Genet Metab; 2002; 77(1-2):127-35. PubMed ID: 12359140
[TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement therapy in mucopolysaccharidosis I: altered distribution and targeting of alpha-L-iduronidase in immunized rats.
Turner CT; Hopwood JJ; Brooks DA
Mol Genet Metab; 2000 Apr; 69(4):277-85. PubMed ID: 10870845
[TBL] [Abstract][Full Text] [Related]
3. Common antigenicity for two glycosidases.
Kakavanos R; Lehn P; Callebaut I; Meikle PJ; Parkinson-Lawrence EJ; Hopwood JJ; Brooks DA
FEBS Lett; 2006 Jan; 580(1):87-92. PubMed ID: 16359666
[TBL] [Abstract][Full Text] [Related]
4. Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I.
Kakavanos R; Turner CT; Hopwood JJ; Kakkis ED; Brooks DA
Lancet; 2003 May; 361(9369):1608-13. PubMed ID: 12747881
[TBL] [Abstract][Full Text] [Related]
5. Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.
Kakkis ED; McEntee MF; Schmidtchen A; Neufeld EF; Ward DA; Gompf RE; Kania S; Bedolla C; Chien SL; Shull RM
Biochem Mol Med; 1996 Aug; 58(2):156-67. PubMed ID: 8812735
[TBL] [Abstract][Full Text] [Related]
6. Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I.
Kakkis E; Lester T; Yang R; Tanaka C; Anand V; Lemontt J; Peinovich M; Passage M
Proc Natl Acad Sci U S A; 2004 Jan; 101(3):829-34. PubMed ID: 14715900
[TBL] [Abstract][Full Text] [Related]
7. Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.
Dickson P; Peinovich M; McEntee M; Lester T; Le S; Krieger A; Manuel H; Jabagat C; Passage M; Kakkis ED
J Clin Invest; 2008 Aug; 118(8):2868-76. PubMed ID: 18654665
[TBL] [Abstract][Full Text] [Related]
8. Glycosidase active site mutations in human alpha-L-iduronidase.
Brooks DA; Fabrega S; Hein LK; Parkinson EJ; Durand P; Yogalingam G; Matte U; Giugliani R; Dasvarma A; Eslahpazire J; Henrissat B; Mornon JP; Hopwood JJ; Lehn P
Glycobiology; 2001 Sep; 11(9):741-50. PubMed ID: 11555618
[TBL] [Abstract][Full Text] [Related]
9. Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation.
Keeling KM; Brooks DA; Hopwood JJ; Li P; Thompson JN; Bedwell DM
Hum Mol Genet; 2001 Feb; 10(3):291-9. PubMed ID: 11159948
[TBL] [Abstract][Full Text] [Related]
10. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
[TBL] [Abstract][Full Text] [Related]
11. Alpha-L-iduronidase and enzyme replacement therapy for mucopolysaccharidosis I.
Brooks DA
Expert Opin Biol Ther; 2002 Dec; 2(8):967-76. PubMed ID: 12517274
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells do not prevent antibody responses against human α-L-iduronidase when used to treat mucopolysaccharidosis type I.
Martin PK; Stilhano RS; Samoto VY; Takiya CM; Peres GB; da Silva Michelacci YM; da Silva FH; Pereira VG; D'Almeida V; Marques FL; Otake AH; Chammas R; Han SW
PLoS One; 2014; 9(3):e92420. PubMed ID: 24642723
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the human lysosomal enzyme alpha-L-iduronidase in Chinese hamster ovary cells.
Kakkis ED; Matynia A; Jonas AJ; Neufeld EF
Protein Expr Purif; 1994 Jun; 5(3):225-32. PubMed ID: 7950365
[TBL] [Abstract][Full Text] [Related]
14. Myoblast gene therapy in canine mucopolysaccharidosis. I: Abrogation by an immune response to alpha-L-iduronidase.
Shull RM; Lu X; McEntee MF; Bright RM; Pepper KA; Kohn DB
Hum Gene Ther; 1996 Aug; 7(13):1595-603. PubMed ID: 8864760
[TBL] [Abstract][Full Text] [Related]
15. Enzyme replacement therapy in feline mucopolysaccharidosis I.
Kakkis ED; Schuchman E; He X; Wan Q; Kania S; Wiemelt S; Hasson CW; O'Malley T; Weil MA; Aguirre GA; Brown DE; Haskins ME
Mol Genet Metab; 2001 Mar; 72(3):199-208. PubMed ID: 11243725
[TBL] [Abstract][Full Text] [Related]
16. Pre-stem cell transplantation enzyme replacement therapy in Hurler syndrome does not lead to significant antibody formation or delayed recovery of the endogenous enzyme post-transplant: a case report.
Soni S; Hente M; Breslin N; Hersh J; Whitley C; Cheerva A; Bertolone S
Pediatr Transplant; 2007 Aug; 11(5):563-7. PubMed ID: 17631030
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of cDNA encoding canine alpha-L-iduronidase. mRNA deficiency in mucopolysaccharidosis I dog.
Stoltzfus LJ; Sosa-Pineda B; Moskowitz SM; Menon KP; Dlott B; Hooper L; Teplow DB; Shull RM; Neufeld EF
J Biol Chem; 1992 Apr; 267(10):6570-5. PubMed ID: 1551868
[TBL] [Abstract][Full Text] [Related]
18. Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients.
Ashton LJ; Brooks DA; McCourt PA; Muller VJ; Clements PR; Hopwood JJ
Am J Hum Genet; 1992 Apr; 50(4):787-94. PubMed ID: 1550122
[TBL] [Abstract][Full Text] [Related]
19. [Hurler syndrome. Early diagnosis and successful enzyme replacement therapy: a new therapeutic approach. Case report].
Dupont C; El Hachem C; Harchaoui S; Ribault V; Amiour M; Guillot M; Maire I; Froissart R; Guffon-Fouilhoux N
Arch Pediatr; 2008 Jan; 15(1):45-9. PubMed ID: 18162380
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-replacement therapy in mucopolysaccharidosis I.
Kakkis ED; Muenzer J; Tiller GE; Waber L; Belmont J; Passage M; Izykowski B; Phillips J; Doroshow R; Walot I; Hoft R; Neufeld EF
N Engl J Med; 2001 Jan; 344(3):182-8. PubMed ID: 11172140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
